HEALTH● LOWJul 21 · Jul 21, 2026, 6:09 AM
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
The Hindu
‘The approval has been granted after a comprehensive scientific evaluation of the vaccine’s quality, safety and efficacy,’ said the Union Health Ministry
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHBREAKING1h agoEvacuated Ebola patient, husband arrive in SwitzerlandPremium TimesHEALTH1h agoRFK Jr. extends MAHA push to hospital foodThe HillHEALTH1h agoEbola: Nigeria Has 54 Primary Contacts Now, Many Are In Quarantine, Says NCDCChannels TVHEALTH2h agoSHRC calls for checks on private clinics after boy’s death following tonsil surgery in KannurThe Hindu